Volume | 0 |
|
|||||
Actualités | - | ||||||
Maximum Haut | Bas Haut |
||||||
Minimum Bas |
Nom Action | Symbole Action | Marché | Type |
---|---|---|---|
Alzamend Neuro Inc | ALZN | NASDAQ | Action ordinaire |
Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
---|---|---|---|---|
0,685 |
Transactions Totales | Volume échangé | Volume en moyenne | Sur 52 semaines |
---|---|---|---|
0 | 0 | - | 0,6516 - 11,91 |
Dernière Transaction | Type | Quantités échangées | Prix transaction | Devise |
---|---|---|---|---|
- | 0 | US$ 0,685 | USD |
Bilan Comptable
Capitalisation Boursière | Actions en Circulation | Float | Chiffre d'affaires | Bénéfice/Perte | BPA | Ratio Cours sur Bénéfices |
---|---|---|---|---|---|---|
4,84M | 7,12M | - | 0 | -14,88M | -2,09 | - |
Short Interest | Dividendes Par Action | Rendement du Dividende | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
plus d’informations financières »
Actualités Action Alzamend Neuro
Date | Heure | Source | Titre |
---|---|---|---|
07/3/2024 | 22:30 | Edgar (US Regulatory) | Form 8-K - Current report |
02/2/2024 | 22:30 | Edgar (US Regulatory) | Form 8-K - Current report |
05/1/2024 | 22:30 | Edgar (US Regulatory) | Form 8-K - Current report |
15/12/2023 | 22:30 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
11/12/2023 | 14:00 | Business Wire | Alzamend Neuro Receives FDA “Study May Proceed” Notification.. |
20/11/2023 | 14:00 | Business Wire | Alzamend Neuro Receives FDA “Study May Proceed” Notification.. |
16/11/2023 | 22:30 | Edgar (US Regulatory) | Form 8-K - Current report |
16/11/2023 | 14:00 | Business Wire | Alzamend Neuro Regains Compliance with Nasdaq’s Minimum Bid.. |
13/11/2023 | 14:00 | Business Wire | Alzamend Neuro Submits IND Application for a Phase IIA.. |
30/10/2023 | 21:30 | Edgar (US Regulatory) | Form 8-K - Current report |
30/10/2023 | 13:00 | Business Wire | Alzamend Neuro Announces Reverse Stock Split |
23/10/2023 | 14:00 | Business Wire | Alzamend Neuro Submits IND Application for a Phase IIA.. |
Forum Action Alzamend Neuro
Aucune Discussion TrouvéeAjouter une Discussion
Historiques Alzamend Neuro Inc
Période | Ouver. | Haut | Bas | VWAP | Moyenne Vol. Quot. | Variation | % |
---|---|---|---|---|---|---|---|
1 semaine | 0,741 | 0,8399 | 0,6516 | 0,7121857 | 41 085 | -0,056 | -7,56% |
1 mois | 1,01 | 1,05 | 0,6516 | 0,842525 | 49 269 | -0,325 | -32,18% |
3 mois | 0,87 | 1,29 | 0,6516 | 1,00 | 57 452 | -0,185 | -21,26% |
6 mois | 3,033 | 3,12 | 0,6516 | 1,39 | 119 703 | -2,35 | -77,42% |
1 an | 9,00 | 11,91 | 0,6516 | 4,23 | 150 764 | -8,32 | -92,39% |
3 ans | 435,00 | 503,25 | 0,6516 | 41,99 | 1 226 404 | -434,32 | -99,84% |
5 ans | 435,00 | 503,25 | 0,6516 | 41,99 | 1 226 404 | -434,32 | -99,84% |